HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ICI 195739

structure given in first source
Also Known As:
2-(2,4-difluorophenyl)-1-(3-(4-(2,2,3,3-tetrafluoropropoxy)styryl)-1,2,4-triazol-1-yl)-3-(1,2,4-triazol-1-yl)propan-2-ol; D 0870; D-0870; D0870; DO870; ICI 195,739; ICI-195739; 1H-1,2,4-Triazole-1-ethanol, alpha-(2,4-difluorophenyl)-3-(2-(4-(2,2,3,3-tetrafluoropropoxy)phenyl)ethenyl)-alpha-(1H-1,2,4-triazol-1-ylmethyl)-
Networked: 30 relevant articles (14 outcomes, 6 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Brener, Z: 2 articles (01/2001 - 07/2000)
2. Molina, J: 2 articles (01/2001 - 07/2000)
3. Harada, T: 2 articles (05/2000 - 04/2000)
4. Matsunaga, T: 2 articles (05/2000 - 04/2000)
5. Mitsui, T: 2 articles (05/2000 - 04/2000)
6. Murano, H: 2 articles (05/2000 - 04/2000)
7. Shibutani, Y: 2 articles (05/2000 - 04/2000)
8. Buckner, Frederick S: 1 article (01/2008)
9. Gref, R: 1 article (01/2001)
10. Rodrigues Júnior JM,: 1 article (01/2001)

Related Diseases

1. Infections
2. Chagas Disease (American Trypanosomiasis)
3. Histoplasmosis
4. Candidiasis (Moniliasis)
5. Acquired Immunodeficiency Syndrome (AIDS)

Related Drugs and Biologics

1. Fluconazole (Zonal)
2. Triazoles
3. Dihydrotachysterol (AT 10)
4. Amphotericin B (Amphotericin)
5. Itraconazole (Sporanox)
6. Ketoconazole (Nizoral)
7. Azoles
8. Flucytosine (Ancobon)
9. posaconazole
10. Catecholamines

Related Therapies and Procedures

1. Oral Administration
2. Therapeutics
3. Nanospheres